Arrowhead Pharmaceuticals Earning Date (ARWR)

USA |NASDAQ |USD

ARWR Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Aug 3, 2022 Jun 2022 - - $-0.29
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Aug 3, 2022 Jun 2022 - - $45.89M

Arrowhead Pharmaceuticals's next earnings date is Wednesday, Aug 3, 2022 for the fiscal quarter ending Jun 2022.

ARWR Earnings Date & History Chart

ARWR Earnings & Revenue Forecast

ARWR Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Sep 2022 12 $-0.48 $-1.98 $1.89

ARWR Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Sep 2022 0 / 0 $-0.48 $-0.48 $-0.45

ARWR Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Sep 2022 12 $240.82M $132.20M $469.70M

ARWR Earnings Date & Revenue History

ARWR Earnings History

|
Show More
Show More

ARWR Revenue History

|
Show More
Show More

Arrowhead Pharmaceuticals Next Earnings Date & Report

ARWR Next Earnings Date & Report Preview: Jun 2022 (FQ)

ARWR's next earnings date is Wednesday, Aug 3, 2022 for the fiscal quarter ending Jun 30, 2022.

Arrowhead Pharmaceuticals Previous Earnings Dates & Reports

ARWR Previous Earnings Date & Report Recap: Mar 2022 (FQ)

Arrowhead Pharmaceuticals's previous earnings date was May 10, 2022 for its fiscal quarter ended Mar 31, 2022.

ARWR Previous Earnings Date & Report Recap: Sep 2021 (FY)

Arrowhead Pharmaceuticals's previous annual earnings date was Nov 22, 2021 for its fiscal year ended Sep 30, 2021.

ARWR's earnings per share (EPS) was $-1.36, missing the consensus analysts forecast of $-0.84 by 61.90% , and lower than the previous year's EPS (Sep 2020) by 61.90%.

Revenues were $138.29M, worse than the forecast of $156.79M by -11.80%, and up by 57.16% from previous year's revenue.

The company reported a net income of $-140.85M.

Arrowhead Pharmaceuticals reported a free cash flow of $147.66M for its fiscal year, compared to $-107.34M a year ago.

The company ended the fiscal year with $25.55M in total debt, an increase of 20.85% compared to the previous year.